Category Archives: Drugs and Devices

The FDA and Regulation – Neurosurgery Partners with FDA for Patient Safety, Innovation and Regulatory Reform

Clemens M. Schirmer, MD, PhD, FAANS, FAHA (left) Vice-Chair, AANS/CNS Communications and Public Relations Committee Geisinger Wilkes Barre, PA Catherine Jeakle Hill (right) Senior Manager for Regulatory Affairs, Washington Office American Association of Neurological Surgeons (AANS) Congress of Neurological Surgeons … Continue reading

Posted in Access to Care, Drugs and Devices, Guest Post, Health, Medical Innovation, Patient Safety, Regulatory Relief | Tagged , , , , , , , , , , |

Cross Post – Efforts to Curb Opioid Misuse Must Preserve Patient Access to Medically-necessary Opioids

For today’s post, we wanted to highlight an opinion piece published by The Hill featuring neurosurgery’s own Robert F. Heary, MD, FAANS, professor of neurological surgery at the Rutgers New Jersey Medical School, and chair of the AANS/CNS Committee on … Continue reading

Posted in Access to Care, Cross Post, Drugs and Devices, Health, Pain | Tagged , , , , , , , |

AANS and CNS Release 2017 Legislative and Regulatory Agenda

On February 14, 2017 the AANS and CNS released their 2017 legislative and regulatory agenda, which includes action items such as improving the health care delivery system, abolishing the Independent Payment Advisory Board (IPAB), expanding support for graduate medical education, … Continue reading

Posted in Access to Care, Antitrust, Coding and Reimbursement, Congress, Drugs and Devices, Emergency Care, GME, Health, Health Reform, Healthcare Costs, HIT, IPAB, MACRA, MedEd, Medical Innovation, Medical Liability, Medicare, Quality Improvement | Tagged , , , , , , , , , , , |